A ten-member European consortium led by Exogenus Therapeutics has secured $14.4 million to develop a disease-modifying ...

Ferring Pharmaceuticals is set to acquire Gameto, a cell engineering company working on new fertility treatments.

EUCROF says the upcoming Ukrainian CRO Association will help show the country remains a strong location for drug trials ...

A recent panel of finance leaders said that companies should stop thinking about fundraising as a last-minute response to ...

Intellectual property enforcement in the life sciences sector is evolving rapidly overall, and in no small part due to ...

Hematology research now needs new evidence strategies as targeted therapies create smaller, more specialized patient groups today ...

Anthropic, the AI lab behind Claude, has filed to go public on Nasdaq under ticker "ANT," though key offering details remain ...

Kos Biotechnology invests in Golden Age Health to widen rare disease access in Asia-Pacific.

New SCRS dashboard measures sponsor and CRO engagement with research sites, offering data-driven insight into partnership ...

Corxel US is merging with Amanat Acquisition Corp in a roughly $377 million deal to fund its oral obesity drug CX11 through ...

“We successfully commercialized a first-in-class antibody for a multi-drug-resistant HIV population,” TaiMed CEO and director ...

Roche has signed a strategic collaboration and license agreement with China's Hansoh Pharma to develop a portfolio of ...